PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES

Authors: P. Knoebl, H. de Haard, W. Parys, P. Ulrichts, F. Rocca, A. Guglietta, J. Ayguasanosa

Published: 2022-06-24

DOI: 10.1097/01.hs9.0000852048.36167.63

Source: Full article

---

Abstract

No abstract found.